CML
Clinical trials for CML explained in plain language.
Never miss a new study
Get alerted when new CML trials appear
Sign up with your email to follow new studies for CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy tested for Hard-to-Treat leukemia
Disease control CompletedThis study tested whether adding a new drug called asciminib to the standard treatment imatinib could help patients with chronic myeloid leukemia (CML) achieve a deeper level of disease control. It involved 104 adults whose CML was not fully controlled by imatinib alone. Particip…
Matched conditions: CML
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New pill tested as potential alternative for leukemia treatment
Disease control CompletedThis study tested a new drug called IkT-001Pro to see if it works similarly in the body to the standard drug, imatinib, used to treat a type of blood cancer called CML. Researchers gave different doses of both drugs to healthy volunteers to compare safety and how the body absorbs…
Matched conditions: CML
Phase: PHASE1 • Sponsor: Inhibikase Therapeutics • Aim: Disease control
Last updated Mar 06, 2026 15:39 UTC